Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Interindividual variability in the extent and duration of platelet thromboxane inhibition by low-dose aspirin

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 29.01.20
Views: 119
Rating:

Prof Bianco Rocca - Catholic University of Rome, Rome, Italy

Prof Bianca Rocca speaks to ecancer at the International Aspirin Foundation Scientific Conference 2019 in Rome about the interindividual variability in the extent and duration of platelet thromboxane inhibition by low-dose aspirin

She explains that aspirin 'resistance' became a major topic, despite many having doubts that a 'resistance' was possible.

Prof Rocca details that pharmacologists are concerned with 'variability' and how people respond to the drug.

Read more on the highlights from the 2019 International Aspirin Foundation Scientific Conference here.

 

Related videos

follow us

Donate to ecancer


Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation